数据链接：
官方服务：
资源简介：
The risks of bias of the included trials.
应用场景：
创建时间：
2016-09-16
相关数据集
Additional file 6 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study
Additional file 6. Assessment of potential bias from age and AMD status in biomarker analyses. Simple regression analysis was performed with AMD status as the predictor for biomarker levels of IL-10,
DataCite Commons2025-03-13 更新90
Newcastle-Ottawa Scale.
Prolonged symptoms of COVID-19 have been found in many patients, often known as Long COVID. Psychiatric symptoms are commonly seen in Long COVID patients and could last for weeks, even months, after r
Figshare2023-04-07 更新60
Additional file 3 of Determining the optimal time for liberation from renal replacement therapy in critically ill patients: a systematic review and meta-analysis (DOnE RRT)
Additional file 3. Risk of Bias Assessment. Complete numerical breakdown of.
NIAID Data Ecosystem30
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Janus kinase inhibitors for the treatment of COVID-19
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Janus kinase inhibitors for the treatment of COVID-19.
NIAID Data Ecosystem70
Quality assessment of included studies.
(1) End points: A, Endpoints appropriate to the aim of the study; B, no description about endpoints; C, endpoints inappropriate to the aim of the study. (2) Follow-up period: A, follow-up appropriate
Figshare2015-12-02 更新50
